Wall Street analyst estimates for NanoVibronix, Inc. (NAOV): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain.
Valuation Ratios
| Price / Book | 0.38 |
| EV / EBITDA | -2.96 |
| Dividend Yield | 0.00% |
Price
| Price | $1.90 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Explore sector: Healthcare · Medical - Devices
More sections of NAOV: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks